Latest Period
Q4 2025
CUSIP: 19188J409
Latest Period
Q4 2025
Institutions Reporting
26
Shares (Excl. Options)
770,490
Price
$0.98
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Latest holder context comes from 26 institutions filings for Q4 2025.
What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 19188J409:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | 18% | +65% | $3,078,992 | +$1,349,571 | 2,462,012 | +78% | Phillip Frost, M.D. | 28 Oct 2025 |
As of 31 Dec 2025, 26 institutional investors reported holding 770,490 shares of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP). This represents 5.6% of the company’s total 13,831,528 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 535 | $540 | -$3,158 | $1.01 | 3 |
| 2025 Q4 | 770,490 | $754,323 | +$52,087 | $0.98 | 26 |
| 2025 Q3 | 664,982 | $831,248 | -$40,108 | $1.25 | 21 |
| 2025 Q2 | 686,516 | $1,022,928 | -$87,903 | $1.49 | 21 |
| 2025 Q1 | 748,773 | $1,064,069 | +$47,078 | $1.42 | 23 |
| 2024 Q4 | 711,389 | $1,437,038 | -$15,989 | $2.02 | 23 |
| 2024 Q3 | 719,274 | $1,265,944 | +$79,057 | $1.76 | 19 |
| 2024 Q2 | 674,355 | $1,571,278 | -$90,505 | $2.33 | 13 |
| 2024 Q1 | 721,322 | $1,013,555 | +$53,963 | $1.40 | 14 |
| 2023 Q4 | 683,341 | $1,173,672 | -$35,542 | $1.72 | 16 |
| 2023 Q3 | 704,225 | $1,316,878 | +$61,523 | $1.87 | 15 |
| 2023 Q2 | 666,895 | $1,594,259 | -$144,985 | $2.39 | 19 |
| 2023 Q1 | 738,638 | $1,468,069 | -$651,598 | $1.99 | 19 |
| 2022 Q4 | 1,065,912 | $2,076,645 | +$2,076,610 | $1.95 | 18 |